PEDS-PLAN - Pediatric Precision Laboratory Advanced Neuroblastoma Therapy- A Pilot Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by Maintenance With DFMO for Subjects With Newly Diagnosed High-Risk Neuroblastoma

Trial Profile

PEDS-PLAN - Pediatric Precision Laboratory Advanced Neuroblastoma Therapy- A Pilot Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by Maintenance With DFMO for Subjects With Newly Diagnosed High-Risk Neuroblastoma

Recruiting
Phase of Trial: Phase I

Latest Information Update: 02 May 2017

At a glance

  • Drugs Bortezomib (Primary) ; Crizotinib (Primary) ; Dasatinib (Primary) ; Lapatinib (Primary) ; Sorafenib (Primary) ; Vorinostat (Primary)
  • Indications Neuroblastoma
  • Focus Therapeutic Use
  • Acronyms PEDS-PLAN
  • Most Recent Events

    • 29 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top